Zankel Todd 4
4 · Raptor Pharmaceutical Corp · Filed Sep 4, 2012
Insider Transaction Report
Form 4
Zankel Todd
Chief Scientific Officer
Transactions
- Sale
Common Stock
2012-08-31$5.00/sh−3,858$19,290→ 652,708 total - Exercise/Conversion
Stock options (right to buy)
2012-08-31−3,642→ 308,921 totalExercise: $2.83From: 2006-11-25Exp: 2016-05-25→ Common Stock (3,642 underlying) - Sale
Common Stock
2012-08-31$5.00/sh−3,642$18,210→ 656,566 total - Sale
Common Stock
2012-08-30$5.00/sh−2,648$13,240→ 656,566 total - Exercise/Conversion
Common Stock
2012-08-31$2.83/sh+3,642$10,307→ 660,208 total
Footnotes (3)
- [F1]Transaction made pursuant to a Rule 10b5-1 trading plan executed on January 9, 2012.
- [F2]Original option grant vests 6/36ths on November 25, 2006 and 1/36th per month thereafter.
- [F3]This transaction was executed in multiple trades at prices ranging from $5.00 to $5.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.